About Xcellerant Ventures
Xcellerant Ventures is a venture capital firm founded in 2020. It is primarily based out of United States. As of Oct 2026, Xcellerant Ventures is an active investor, having invested in 13 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and High Tech. Most recently it participated in the $***** Series A round of Geneticure Overall, Xcellerant Ventures portfolio has seen 1 acquisition, namely TTI. A lot of funds co-invest with Xcellerant Ventures, with names like Osage Venture Partners sharing a substantial percentage of its portfolio. Xcellerant Ventures has team of 10 people including 5 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A & Series B
Portfolio Acquisitions
Deals in last 12 months
Xcellerant Ventures' List of Top Investments
Xcellerant Ventures has a portfolio of 13 companies. Their most notable investments are in Tesis Labs and CRISPR QC.Their portfolio spans across United States and France. They have invested in HealthTech, Life Sciences, High Tech and 3 other sectors, across stages such as Series A, Series B stages. Here is the list of top investments by Xcellerant Ventures:
1. DeepLook
Digital precision decision-making tools for medical diagnosis. The company has developed software such as DL Precise which has been built for automated measurement and analysis of medical images. The system can be used by professionals to measure suspicious masses in mammograms, CT scans, and ultrasound images. The software has the ability to characterize tumors for treatment plans, calculate growth rate over time, and tumor shrinkage time as well.
Key facts about DeepLook
- Founded Year: 2019
- Location: New Haven (United States)
- Stage: Series A
- Total Funding till date: $5.75M
- Employee Count: 19 as on Sep 30, 2026
- Investors: Connecticut Innovations, Angel Investor Forum and 4 Others
- Latest Funding Round: Series A, Sep 18, 2024, $*****
- Highlight: Editors' Pick
Key facts about Lenoss Medical
- Founded Year: 2016
- Location: Raynham (United States)
- Stage: Series A
- Total Funding till date: $7.3M
- Employee Count: 16 as on Sep 30, 2026
- Investors: Slater Technology Fund, Cherrystone Angel Group and 10 Others
- Latest Funding Round: Series A, Mar 17, 2026, $*****
3. Nanodropper
Nanodropper manufactures adaptors that reduce the volume of the droplet coming from the eyedrop bottle, reducing the chances for overdosing, wastage and cost. This adaptor is a one-size-fits-most for a specific bottle type making it useful for most of the eyedrop bottles.
Key facts about Nanodropper
- Founded Year: 2018
- Location: Seattle (United States)
- Stage: Seed
- Total Funding till date: $2.51M
- Employee Count: 9 as on Sep 30, 2026
- Investors: Alliance of Angels, Golden Seeds and 4 Others
- Latest Funding Round: Seed, Apr 19, 2021, $*****
4. Geneticure
Personalized hypertension treatment through DNA analysis for better medication selection. This company is dedicated to personalizing the treatment of hypertension and other chronic diseases. They provide clinicians with tools to personalize therapy based on a patient's unique DNA, leveraging genomics and integrative physiology to develop tests that help patients recover faster and more cost-effectively. Their approach aims to reduce trial-and-error in medication selection, guiding physicians to prescribe the right treatment from the start. They focus on precision medicine, pharmacogenomics, and pharmacogenetics to offer clinical decision support for high blood pressure management. Their innovative solutions have the potential to improve patient outcomes and reduce healthcare costs, making a significant impact on the management of chronic conditions.
Key facts about Geneticure
- Founded Year: 2012
- Location: Minnetonka (United States)
- Stage: Series A
- Total Funding till date: $2.12M
- Employee Count: 9 as on Sep 30, 2026
- Investors: M25, Wireframe Ventures and 2 Others
- Latest Funding Round: Series A, Oct 21, 2026, $*****
Xcellerant Ventures' Year-on-Year Investment Trends
Xcellerant Ventures has invested in 13 companies over the last 5 years, with an average of 1 new investment annually in the last 5 years. In 2025, it made 1 investment, while as of Oct 2026, it has made 2 investments in this year. Its most recent first time investment was in Geneticure and most recent follow-on round was in Lenoss Medical.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 1 | 0 | 1 |
2024 | 2 | 0 | 2 |
2023 | 2 | 0 | 2 |
2022 | 0 | 0 | 0 |
2021 | 1 | 0 | 1 |
Xcellerant Ventures' Investments by Stage
Xcellerant Ventures has made 6 investments in Series A stage with an average round size of $3.92M and 1 investment in Series B stage with an average round size of $20M.Stage of entry | No. of Investments |
|---|---|
Series A | 6 |
Series B | 1 |
Note: We have considered here, only first round of investments
Xcellerant Ventures' Investments by Sector
Xcellerant Ventures has a diverse portfolio, with companies operating in the HealthTech, Life Sciences, Enterprise Applications, High Tech and Vertical SaaS. Notably, it has invested in 11 Enterprise (B2B) companies, 10 Tech companies, 6 Software companies and at least 2 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
HealthTech | 4 |
Life Sciences | 3 |
Enterprise Applications | 2 |
High Tech | 2 |
Vertical SaaS | 2 |
Others | 2 |
Note: We have considered here, only first round of investments
Xcellerant Ventures' Investments by Geography
Xcellerant Ventures has made most investments in United States (7).Xcellerant Ventures' recent investments
Xcellerant Ventures has made 2 investments in 2026 so far - Geneticure and Lenoss Medical.Here are the most recent investments by Xcellerant Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 21, 2026 | United States | Series A | 2623 | - | |
Mar 17, 2026 | United States | Series A | 8098 | ||
Sep 03, 2025 | United States | Series A | 7006 | - | |
Sep 18, 2024 | United States | Series A | 1898 | ||
Jan 02, 2024 | United States | Series A | 1196 | - |
Acquired companies in Xcellerant Ventures' Portfolio
1 company from Xcellerant Ventures' portfolio has been acquired. The most recent acquisition was TTI in Jun 2023 by Inframark for $*****.Here are Xcellerant Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 28, 2023 | - | - | 1509 |
Team profile of Xcellerant Ventures
Xcellerant Ventures has a team of 10 members including 5 Partners and 1 Principal located in United States and Pakistan. Xcellerant Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Xcellerant Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Los Angeles | - | ||
Partner | Phoenix | - | ||
Partner | Paradise Valley | - | ||
Partner | Scottsdale | - | ||
Partner | United States | - | ||
Principal | Lahore | - | - |
Co-investors of Xcellerant Ventures
Over the past 5 years, 23 investors have co-invested in Xcellerant Ventures's portfolio companies. This includes only funds.
- Invested before Xcellerant Ventures: OKG Capital, Connecticut Innovations and 15 others have invested in rounds before Xcellerant Ventures. There is 1 company where OKG Capital has invested before Xcellerant Ventures and 1 company where Connecticut Innovations has invested before Xcellerant Ventures.
- Top Co-investors of Xcellerant Ventures: 2 investors entered a company along with Xcellerant Ventures. These include investors like Osage Venture Partners (1 company).
- Invested after Xcellerant Ventures: A total of 4 investors have invested in Xcellerant Ventures's portfolio after their investments. Top Investors include Arizona Venture Development (1 company), RightHill Ventures (1 company) and Highpoint Ventures (1 company).
Recent News related to Xcellerant Ventures
•
Lenoss Medical Closes $6M Growth Bridge Financing RoundOrthopedics•Mar 17, 2026•RightHill Ventures, Arizona Venture Development, Lenoss Medical, Xcellerant Ventures
•
Xcellerant Ventures Launches Jetstream Venture Fund, Expanding VC Investing AccessPR Newswire•Oct 09, 2025•Xcellerant Ventures
•
Mindset Medical Receives Additional FundingFinSMEs•Oct 09, 2025•Informed Mindset Medical, Arizona Venture Development, Grayhawk Capital, Xcellerant Ventures
•
Xcellerant Ventures Invests in Mindset Medical to Advance Contactless Vital Sign MonitoringBusiness Wire•Oct 07, 2025•Xcellerant Ventures, Informed Mindset Medical
•
Xcellerant Ventures, AVC to invest $7 million into health tech startupsThe Business Journals•Mar 28, 2025•Xcellerant Ventures, Arizona Venture Development
•
DeepLook Medical Announces First Close of Series A Funding Round; Releases Promising Data on Cancer Detection TechnologyFemtech Insider•Sep 19, 2024•DeepLook, Xcellerant Ventures
•
Xcellerant Ventures Ends First Year with 10th Investment, Leading CRISPR QC’s $10 Million Series A RoundBusiness Wire•Jan 05, 2024•Xcellerant Ventures, CRISPR QC
•
CRISPR QC Secures Funding from Xcellerant Ventures in Series A RoundFinSMEs•Jan 05, 2024•CRISPR QC, Xcellerant Ventures
•
Xcellerant Ventures Invests in Series A Funding Round for Lenoss MedicalFinancial Post•Dec 13, 2023•Lenoss Medical, Xcellerant Ventures
•
TruLite Health Closes $7.0 Million Series A Funding Round Led by Osage Venture PartnersBusiness Wire•Aug 29, 2023•TruLite Health, Osage Venture Partners, Xcellerant Ventures, Ensemble Innovation Ventures and 1 other
